ALXN : Analysis & Opinions

  1. Bull of the Day: Alexion Pharma (ALXN) - Bull of the Day

    February 24, 2014
    Bull of the Day: Alexion Pharma (ALXN) - Bull of the Day
  2. Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook

    July 30, 2013
    Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
  3. Roche Delivering Leverage, But Still Needs Diversification

    July 29, 2013
    If Roche can balance out its sales mix, the long-term value could be quite compelling at present prices.
  4. Alexion on Roche's Radar? - Analyst Blog

    July 15, 2013
    According to Bloomberg News, Alexion Pharma is being eyed by Roche
  5. Theravance's Vibativ Expanded in the US - Analyst Blog

    June 24, 2013
    The FDA approved Vibativ for an additional indication.
  6. Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog

    June 13, 2013
    Median progression free survival was better in the trebananib arm compared to the control arm.
  7. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  8. Celgene Among Healthcare's Biggest Movers on January 2, 2013

    January 2, 2013
    The market is having a good day so far: the Nasdaq has risen 2.3%; the S&P 500 is up 1.8%; and the Dow has climbed 1.9%. ...
  9. Intuitive Surgical Among Healthcare's Biggest Movers on December ...

    December 26, 2012
    The market is having a bad day so far: the Nasdaq has declined 1.1%; the S&P 500 is trading down 0.6%; and the Dow has fallen ...
  10. Celgene and More Big Movers in Healthcare on December 10, 2012

    December 10, 2012
    On a good day for the market, the Nasdaq is trading up 0.6%, the S&P 500 is up 0.2% and the Dow has increased 0.3%. The healthcare ...
  11. Alexion Pharmaceuticals and More Big Movers in Healthcare on ...

    December 7, 2012
    So far today, the Nasdaq is down 0.7%, the S&P 500 is unchanged and the Dow is trading up 0.3%. The healthcare sector is ...
  12. Alexion Pharmaceuticals and Other Big Movers on the Nasdaq on ...

    December 7, 2012
    The Nasdaq has decreased 0.7%, the S&P 500 has remained steady and the Dow has climbed 0.3% so far today. The recent surge ...
  13. Alexion Pharma Evenly Poised - Analyst Blog

    December 3, 2012
    We are maintaining our Neutral recommendation on Alexion Pharmaceuticals, Inc. (ALXN) with a target price of $100.00. The ...
  14. Alexion Pharmaceuticals Among Healthcare's Biggest Movers on ...

    October 23, 2012
    It's been a bad day for the market after the morning's trading. The Nasdaq has decreased 0.8%; the S&P 500 is down 1.5%; ...
  15. Alexion Pharmaceuticals and Other Big Movers In Healthcare on ...

    October 8, 2012
    The Nasdaq has fallen 1%, the S&P 500 has declined 0.4% and the Dow is trading down 0.3%, marking a bad morning for the market. ...
  16. Healthcare Stocks, Including Eli Lilly, Making Big Moves on August ...

    August 24, 2012
    The Nasdaq has increased 0.6%, the S&P 500 has risen 0.5% and the Dow has moved up 0.6% on a good day for the market so far. ...
  17. Biggest Healthcare Sector Movers, Including ALXN

    August 3, 2012
    On a good day for the market, the Nasdaq has climbed 2.2%, the S&P 500 has increased 2% and the Dow is up 1.8%. The healthcare ...
  18. Biggest Healthcare Sector Movers for July 23, 2012, Including ...

    July 23, 2012
    It's been a bad day for the market after the morning's trading. The Nasdaq is down 1.9%; the S&P 500 has fallen 1.3%; and ...
  19. Nasdaq 100's Most Overbought Stocks

    April 24, 2012
    Close proximity to technically overbought levels means that these fast-gaining Nasdaq 100 stocks carry high risk at current ...
  20. 3 Small Caps with Good Earnings Records

    April 19, 2012
    Not only are large, liquid market leaders earnings winners, but so are some of the little-known small caps. Here are three ...
  21. Merck's Penance Has Gone On Long Enough

    October 31, 2011
    Merck won't grow fast, but it's quality is undervalued. It's time for investors to reevaluate it.
  22. 4 Stocks with Strong Earnings Forecasts

    August 12, 2011
    While technicals matter most when it comes to entering or exiting a position, a company’s earnings growth is what draws ...
  23. July's Healthcare Winners

    August 5, 2011
    Check out July's Best Performing Healthcare Stocks!
  24. Time For Gilead To Open Its Wallet

    July 6, 2010
    Gilead has carved out an exceptionally valuable niche, but should the company do more?
  25. Is Another Wave Of Biotech M&A On The Way?

    July 2, 2010
    If biotech companies are buying each other, should investors get in on the action?
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center